Med D populations represent between 30-40% of the independent community pharmacist’s patient population.  Historically, we’ve always used October as a defensive strategy to retain current patients, and help them navigate and find the best plans.  Industry expert Michele Elliott joins Justin Baker to add a new twist to the conversation.

Michele proposes that we leverage this opportunity to position ourselves as a healthcare destination for NEW patients. Profitable patients with expectations of point-of-care testing, chronic disease monitoring, and test to treat options that fill care gaps.